The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine
Open accessAbstract
Significance: Our work shows a remarkable synergy between physiological levels of vitamin C and 5-aza-CdR. The combination enhances the viral mimicry response to DNA methyltransferase inhibitors, including the upregulation of endogenous retroviruses in the dsRNA form and the induction of viral defense pathways. Because patients with hematological and other cancers are often markedly vitamin C deficient, the addition of vitamin C to treatment protocols may be a straightforward way to increase the clinical efficacy of such drugs in patients with myelodysplastic syndrome and leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, on the basis of ascorbate’s known DNA demethylation effects via TET activation, a recent study found that vitamin C enhanced the effect of the DNMT inhibitor 5-aza-CdR (decitabine) by promoting the demethylation of human endogenous retroviruses and amplifying the expression of interferon-stimulated genes, leading to cancer cell death106,107.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [106]
In the citing paper
“Interestingly, a recent report in a small cohort of patients (n=24) with haematological malignancies showed that >90% had decreased plasma vitamin C concentrations and 58% were classified as vitamin C deficient.56”
From Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia (2018) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 444
RetractedConversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Self-citationA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Self-citationFenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Self-citationDecitabine improves patient outcomes in myelodysplastic syndromes
Kantarjian, H. M., Issa, J. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M. X., DiPersio, J. F., Klimek, V. M., Slack, J. L., de Castro, C., Ravandi, F., et al. (2006) · Cancer · doi:10.1002/cncr.21792 · Cited by 1,539
Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S. Y., Han, H., Liang, G., Jones, P. A., Pugh, T. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.056 · Cited by 1,527
Self-citation
Cited by
Sorted by citations
Items 101–200 of 230
Topham, J. T., Titmuss, E., Pleasance, E., Williamson, L. M., Karasinska, J. M., Culibrk, L., Lee, M. K. C., Mendis, S. R., Denroche, R. E., Jang, G.-H., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0094 · Cited by 27
The Result of Vitamin C Treatment of Patients with Cancer: Conditions Influencing the Effectiveness
Hunyady, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084380 · Cited by 29
Balestrieri, E., Argaw-Denboba, A., Gambacurta, A., Cipriani, C., Bei, R., Serafino, A., Vallebona, P. S., & Matteucci, C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01448 · Cited by 24
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
Jung, I., An, J., & Ko, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030654 · Cited by 22
Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review)
Renner, O., Burkard, M., Michels, H., Vollbracht, C., Sinnberg, T. W., & Venturelli, S. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5215 · Cited by 24
Hunt, K. V., Burnard, S. M., Roper, E. A., Bond, D. R., Dun, M. D., Verrills, N. M., Enjeti, A. K., & Lee, H. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-09765-x · Cited by 23
Activation of viral defense signaling in cancer
González‐Cao, M., Karachaliou, N., Santarpía, M., Viteri, S., Meyerhans, A., & Rosell, R. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918793105 · Cited by 21
Son, E. S., Kim, S. H., Kim, Y. O., Lee, Y. E., Kyung, S. Y., Jeong, S. H., Kim, Y. J., & Park, J.-W. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2725-z · Cited by 20
Rewiring of chromatin state and gene expression by transposable elements
Ohtani, H., & Iwasaki, Y. W. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12735 · Cited by 23
Self-citationWłodarczyk, M., Nowicka, G., Ciebiera, M., Ali, M. K., Yang, Q., & Al-Hendy, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052720 · Cited by 19
DNA methylation in cell plasticity and malignant transformation in liver diseases
Kim, M., Delgado, E. R., & Ko, S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108334 · Cited by 20
DNA methyltransferase inhibitors in hematological malignancies and solid tumors
Wenger, V., Garcia‐Manero, G., Zeiser, R., & Lübbert, M. (2025) · International Journal of Cancer · doi:10.1002/ijc.70197 · Cited by 18
Onishi‐Seebacher, M., Erikson, G. A., Sawitzki, Z., Ryan, D., Greve, G., Lübbert, M., & Jenuwein, T. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01003-z · Cited by 19
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
Brabson, J. P., Leesang, T. E., Yap, Y. S., Wang, J., Lam, M. Q., Fang, B., Dolgalev, I., Barbieri, D. A., Strippoli, V., Bañuelos, C. P., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112027 · Cited by 18
Fan, Y., Li, L., & Sun, S. (2024) · Genome biology · doi:10.1186/s13059-024-03237-3 · Cited by 24
Foster, M. N., Carr, A. C., Antony, A., Peng, S., & Fitzpatrick, M. (2018) · Antioxidants · doi:10.3390/antiox7070092 · Cited by 18
Alldredge, J. K., Kumar, V., Nguyen, J., Sanders, B. E., Gomez, K. E., Jayachandran, K., Zhang, J., Schwarz, J. K., & Rahmatpanah, F. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021492 · Cited by 17
Vitamin C and D supplementation in acute myeloid leukemia
Mouchel, P., Bérard, E., Tavitian, S., Gadaud, N., Vergez, F., Rieu, J., Luquet, I., Sarry, A., Huguet, F., Largeaud, L., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010559 · Cited by 17
Antioxidant Roles/Functions of Ascorbic Acid (Vitamin C)
Agwu, E., Ezihe, C. O., & Kaigama, G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110589 · Cited by 23
Emran, A. A., Marzese, D. M., Menon, D. R., Hammerlindl, H., Ahmed, F., Richtig, E., Duijf, P. H. G., Hoon, D. S. �., & Schaider, H. (2019) · Epigenomics · doi:10.2217/epi-2018-0173 · Cited by 19
Travaglini, S., Gurnari, C., Antonelli, S., Silvestrini, G., Noguera, N. I., Ottone, T., & Voso, M. T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.930205 · Cited by 18
Liu, J., Min, S., Kim, D., Park, J., Park, E., Koh, Y., Shin, D.-Y., Kim, T. K., Byun, J. M., Yoon, S., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01493-x · Cited by 17
Hoang, N.-M., Liu, Y., Bates, P. D., Heaton, A. R., Lopez, A. F., Liu, P., Zhu, F., Chen, R., Kondapelli, A., Zhang, X., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101484 · Cited by 20
Out of sight, out of mind? Germ cells and the potential impacts of epigenomic drugs
Jarred, E. G., Bildsoe, H., & Western, P. S. (2018) · F1000Research · doi:10.12688/f1000research.15935.1 · Cited by 17
Liang, J., Na, X., Meng, L., He, L., Shu, T., Fang, Y., Zhang, B., Zhao, Z., Guo, C., Li, J., et al. (2025) · MedComm · doi:10.1002/mco2.70245 · Cited by 15
Viral mimicry in cancer therapy
Rosenberg, L., & Vabret, N. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.010 · Cited by 19
Regulation and Functional Significance of 5-Hydroxymethylcytosine in Cancer
Arvinden, V. R., Rao, A. K. D. M., Rajkumar, T., & Mani, S. (2017) · Epigenomes · doi:10.3390/epigenomes1030019 · Cited by 15
Double-stranded RNA induction asa potential dynamic biomarkerfor DNA-demethylating agents
Kang, M., Kharbash, R., Byun, J. M., Jeon, J., Ali, A. A., Ku, D., Yoon, J., Ku, Y., Sohn, J., Lee, S., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.014 · Cited by 14
Grady, C. I., Walsh, L. M., & Heiss, J. D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1154753 · Cited by 14
Chen, S., Zhou, Q., Liu, T., Zhang, W., Zeng, X., & Guo, Z. (2019) · Journal of Cancer · doi:10.7150/jca.38283 · Cited by 14
Cao, X., Yi, Y., Ji, M., Liu, Y., Wang, D., & Zhu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1633447 · Cited by 13
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
Humphries, S., Bond, D. R., Germon, Z. P., Keely, S., Enjeti, A. K., Dun, M. D., & Lee, H. J. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01566-x · Cited by 15
Vitamin C promotes anti-leukemia of DZNep in acute myeloid leukemia
Long, B., Shan, Y., Sun, Y., Wang, T., Li, X., Huang, K., Zhang, W., He, Y. J., Wen, R., Li, Y., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166357 · Cited by 13
Khan, M. I., Nur, S. M., & Abdulaal, W. H. (2022) · Oncology Letters · doi:10.3892/ol.2022.13339 · Cited by 13
Ohtani, H., Liu, M., Liang, G., Jang, H. J., & Jones, P. A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae498 · Cited by 13
Self-citationA perspective on diet, epigenetics and complex diseases: where is the field headed next?
Coppedè, F., Franzago, M., Giardina, E., Nigro, C. L., Matullo, G., Moltrasio, C., Nacmias, B., Pileggi, S., Sirchia, S. M., Stoccoro, A., et al. (2022) · Epigenomics · doi:10.2217/epi-2022-0239 · Cited by 12
Mastrangelo, D., Massai, L., Fioritoni, G., & Lo‐Coco, F. (2017) · InTech eBooks · doi:10.5772/intechopen.68746 · Cited by 13
Epigenetic drugs: More than meets the eye
Esteller, M. (2017) · Epigenetics · doi:10.1080/15592294.2017.1322881 · Cited by 11
Epigenetically programmed resistance to chemo- and immuno-therapies
Walker, R. R., Rentia, Z., & Chiappinelli, K. B. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2022.12.001 · Cited by 13
Retinoic acid-inducible gene-I like receptor pathway in cancer: modification and treatment
Du, G., Xing, Z., Zhou, J., Cui, C., Liu, C., Liu, Y., & Li, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1227041 · Cited by 10
Inflammatory mitochondrial signalling and viral mimicry in cancer
Nesci, S., Marchi, S., Hu, J. K., Marincola, F. M., & Algieri, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06931-3 · Cited by 14
Liu, J., Min, S., Kim, D. C., Park, J., Park, E., Pei, S., Koh, Y., Shin, D., Byun, J. M., Ko, M., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01954-5 · Cited by 12
Premnath, N., Chung, S. S., Weinberg, O. K., Ikpefan, R., Pandey, M., Kaur, G., Geethakumari, P. R., Afrough, A., Awan, F. T., Anderson, L. D., et al. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.107001 · Cited by 9
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism
Gutierrez, W. R., Scherer, A., Rytlewski, J. D., Laverty, E. A., Sheehan, A. P., McGivney, G. R., Brockman, Q. R., Knepper-Adrian, V., Roughton, G. A., Quelle, D. E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159419 · Cited by 9
Gąbka, M., Dałek, P., Przybyło, M., Gackowski, D., Oliński, R., & Langner, M. (2021) · Cells · doi:10.3390/cells10112964 · Cited by 9
Transposable elements activation triggers necroptosis in mouse embryonic stem cells
Jin, L., He, J., Feng, H., Li, S., Liu, H., Dong, H., Hu, M., Huang, J., Wu, H., Chen, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05705-3 · Cited by 11
Testa, U., Pelosi, E., & Castelli, G. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2020.11.002 · Cited by 8
Vitamin C activates young LINE-1 elements in mouse embryonic stem cells via H3K9me3 demethylation
Cheng, K. C. L., Frost, J. M., Sanchez-Luque, F. J., García-Cañadas, M., Taylor, D., Yang, W. R., Irayanar, B., Sampath, S., Patani, H., Agger, K., et al. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00514-6 · Cited by 8
Zhao, X. O., Zong, J., Liu, Y., Aili, T., Qiu, M., Wu, J., & Hu, B. (2024) · Aging and Disease · doi:10.14336/ad.2024.0123-1 · Cited by 7
Reid, M. A., Sanderson, S. M., & Locasale, J. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00009-8 · Cited by 9
Puccini, A., Loupakis, F., Stintzing, S., Cao, S., Battaglin, F., Tokunaga, R., Naseem, M., Berger, M. D., Soni, S., Zhang, W., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.01.105 · Cited by 6
Self-citationOxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics
Yang, X., Chen, Q., Yu, Y., Zang, Y., Zheng, R., Zhang, Z., Lu, S., & Zhou, L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70065 · Cited by 7
Rosano, D., Sofyalı, E., Dhiman, H., Ivanoiu, D., Slaven, N., Hong, S. P., Rocca, A., Bravaccini, S., Ravaioli, S., Noberini, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.21.440779 · Cited by 8
Tian, S. I. P., & Chen, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1466156 · Cited by 5
Ação antioxidante e propriedades funcionais do morango no organismo humano
Nunes, G., & Novello, D. (2021) · Revista Valore · doi:10.22408/reva502020246e-5004 · Cited by 5
Tiedemann, R. L., Eden, H. E., Huang, Z., Robertson, K. D., & Rothbart, S. B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1294-1_7 · Cited by 5
Bond, D. R., Burnard, S. M., Uddipto, K., Hunt, K. V., Harvey, B. M., Reinhardt, L. S., Lawlor-O’Neill, C., Roper, E. A., Humphries, S., Murray, H. C., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02693-5 · Cited by 4
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancerPreprint
Deblois, G., Tonekaboni, S. A. M., Kao, Y. I., Tai, F., Liu, X., Ettayebi, I., Guilhamon, P., Fedor, A. N., Grillo, G., Murison, A. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/286054 · Cited by 4
Viral mimicry acts as a tumor suppressor in colitis
Larsen, F., Jeong, W., Schep, D., Good, H. J., Shin, A. E., Zhang, L., Derouet, M., Wang, T. C., Castellani, C. A., Shooshtari, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68850-1 · Cited by 4
The physiological functions of ascorbate in the development of cancer
Agathocleous, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052201 · Cited by 4
Jin, W., Yao, H., Wang, X., Li, M., Gao, X., Chen, W., & Zhang, Y. (2025) · Journal of Materials Chemistry C · doi:10.1039/d4tc04412f · Cited by 3
Self-citationVitamins and dietary supplements in cancer treatment: is there a need for increased usage?
Esposito, T., Pentimalli, F., Giordano, A., & Cortellino, S. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2501077 · Cited by 4
Momparler, R. L., Côté, S., & Momparler, L. F. (2021) · Epigenomes · doi:10.3390/epigenomes5020007 · Cited by 4
DNA Methylation Changes in Cancer
Thomson, J. P., & Meehan, R. R. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59786-7_4 · Cited by 3
High Doses of Vitamin C and Leukemia: In Vitro Update
Mastrangelo, D., Massai, L., Fioritoni, G., Lo‐Coco, F., Noguera, N. I., & Testa, U. (2018) · InTech eBooks · doi:10.5772/intechopen.71484 · Cited by 3
PRC2 Loss and DNMT Inhibition Boost Viral Mimicry in Cancer
Guil, S., & Esteller, M. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0733 · Cited by 3
Evolvability and emergence of tumor heterogeneity as a space–time function
Saha, B., Vannucci, L. E., Saha, B., Tenti, P., & Baral, R. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156061 · Cited by 3
KnowYourCG: Facilitating base-level sparse methylome interpretation
Goldberg, D. C., Fu, H., Atkins, D., Moyer, E. J., Lee, C. N., Deng, Y., & Zhou, W. (2025) · Science Advances · doi:10.1126/sciadv.adw3027 · Cited by 4
Self-citationMedical applications of stabilized ascorbic acid: a review of recent advances
Kim, Y., & Choi, G. (2023) · Medical Lasers · doi:10.25289/ml.23.032 · Cited by 2
L-Ascorbic Acid in the Epigenetic Regulation of Cancer Development and Stem Cell Reprogramming
Kovina, A. P., Petrova, N. V., Razin, S. V., & Kantidze, O. L. (2020) · Acta Naturae · doi:10.32607/actanaturae.11060 · Cited by 2
DNA-Demethylating Agents Enhance Cytolytic Activity of CD8 T Cells and Anti-Tumor ImmunityPreprint
Yau, H. L., Chakravarthy, A., de Almeida, F. C., Allard, D., Singhania, R., Ettayebi, I., Shen, S. Y., Medina, T. D. S., Mehdipour, P., Morancho, B., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155506 · Cited by 2
Bellastella, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734936741.793557350 · Cited by 2
Lessons Learned from Cancer Metabolism for Physiology and DiseasePreprint
Campbell, S. L., & Christofk, H. R. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041554 · Cited by 2
The interplay between H3K36 methylation and DNA methylation in cancer
Dan, J., Du, Z., Zhang, J., & Chen, T. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0234 · Cited by 1
The Vitamin C Level in Cases with Hematological Malignancies
Sincan, G., Erdem, F., & Kızıltunç, A. (2024) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1458028 · Cited by 1
Mikkelsen, S. U., Al-Mousawi, A., Puglisi, A. B., Vallentin, A. P., Mortensen, A. Ø., Madaj, Z., Hinoue, T., Ottesen, H. N., Jespersen, J. S., Gillberg, L., et al. (2026) · Cancer · doi:10.1002/cncr.70549 · Cited by 2
Self-citationTargeting Epigenetic Modifiers for Cancer Treatments
Chee, C. S., & Leung, D. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0130-9 · Cited by 1
Vitamin C: Current Concepts in Human Physiology
Carr, A. C., & Natarajan, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-295-2 · Cited by 1
Use of vitamins and minerals as dietary supplements for better health and cancer prevention
Arfin, S., & Kumar, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19193-0.00003-4 · Cited by 1
The epigenomic impact of methylation in metabolic dysfunction and cancer
Zahnow, C. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816843-1.00005-9 · Cited by 1
Viegas, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617318113
Weisenberger, D. J. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.008
Choi, H., Kwon, J., Sun, J., Cho, M. S., Sun, Y., Casey, J. L., Toretsky, J. A., & Han, C. (2020) · doi:10.21203/rs.3.rs-60342/v1
Epigenetics in diagnosis, prognosis and therapy
Qazi, S., & Sharma, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819753-0.00019-2
Novel approach in various types of cancer treatments
Patil, S. A., Shinde, K. S., Choudhary, H. B., Patekar, R. R., & Rede, S. D. (2021) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2021.10.3.0291
Extreme Activation of Androgen Receptor for Prostate Cancer Therapy
Alizadeh‐Ghodsi, M. (2021) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Rundquist, O. (2021) · Linköping studies in science and technology. Dissertations · doi:10.3384/9789179291044
Schellhorn, H. E. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.729069935.793537498
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.2
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.3
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.4
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.5
Data from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Kelly, G., Al‐Ejeh, F., McCuaig, R., Casciello, F., Kamal, N. A., Ferguson, B., Pritchard, A. L., Ali, S., Silva, I. P., Wilmott, J. S., et al. (2023) · doi:10.1158/1078-0432.c.6531297
Data from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Kelly, G., Al‐Ejeh, F., McCuaig, R., Casciello, F., Kamal, N. A., Ferguson, B., Pritchard, A. L., Ali, S., Silva, I. P., Wilmott, J. S., et al. (2023) · doi:10.1158/1078-0432.c.6531297.v1
Choi, H., Kwon, J., Cho, M. S., Sun, Y., Zheng, X., Wang, J., Bouker, K. B., Casey, J. L., Atkins, M. B., Toretsky, J. A., et al. (2023) · doi:10.1158/0008-5472.c.6513106.v1
Methylation and hydroxymethylation in cancer
Asmar, F., Gillberg, L., & Grønbæk, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91367-6.00020-9
Self-citationStress-induced endogenous-dsRNAs drive beta-cells to IFN-I statePreprint
Chi, K. K., Senapati, P., Leung, A., & Schones, D. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.10.566600
DNA methylation in T cell leukaemia
Bensberg, M. (2024) · Linköping University medical dissertations · doi:10.3384/9789180755405
Metadata
- Authors
- Liu, M., Ohtani, H., Zhou, W., Ørskov, A. D., Charlet, J., Zhang, Y. W., Shen, H., Baylin, S. B., Liang, G., Grønbæk, K., & Jones, P. A.
- Affiliations
- Van Andel Institute (US)
- Rigshospitalet (DK)
- University of Southern California (US)
- Johns Hopkins University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-08-29
- Volume
- 113
- Issue
- 37
- Pages
- 10238-10244
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5027469
- OpenAlex
- W2507387671
- Cited by
- 225
- References
- 49
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 41 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 21 · 2016: 2
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Funders
- HHS | NIH | National Cancer Institute (R01CA082422)
- American Association for Cancer Research (Stand Up To Cancer Epigenetics Dream Team)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- scurvy, decitabine, hypomethylating agents, hematologic malignancies, endogenous retroviruses, viral mimicry, TET2, 5-hydroxymethylcytosine, 5-methylcytosine, interferon response, apoptosis, epigenetic therapy, vitamin C supplementation
- MeSH terms
- Decitabine, Ascorbic Acid, Ascorbic Acid Deficiency, Azacitidine, DNA-Binding Proteins, Drug Synergism, Enzyme Inhibitors, Female, Humans, Interferons, Male, Methyltransferases, Proto-Oncogene Proteins, RNA, Double-Stranded, Apoptosis, DNA Methylation, Hematologic Neoplasms, Endogenous Retroviruses, Cell Proliferation, Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review